Evelo Biosciences, Inc.
EVLO
$0.0003
-$0.0002-40.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 31.17% | 18.12% | 11.17% | 6.26% | 2.40% |
| Total Depreciation and Amortization | -24.77% | -13.65% | -9.51% | -7.04% | -6.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.65% | -0.65% | -15.12% | -1.27% | 5.15% |
| Change in Net Operating Assets | -37.93% | 29.70% | -2,775.81% | -567.41% | -164.23% |
| Cash from Operations | 30.40% | 22.26% | 6.84% | -4.66% | -20.56% |
| Capital Expenditure | -685.71% | 66.93% | 64.58% | 59.05% | 102.07% |
| Sale of Property, Plant, and Equipment | 1,650.00% | -- | -- | -- | 433.33% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 237.04% | 65.37% | 63.56% | 58.00% | 103.42% |
| Total Debt Issued | -- | -- | 201.04% | 201.04% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -63.46% | -93.01% | 12,191.00% | 2.28% | -10.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1,758.33% | -- | -- |
| Cash from Financing | -73.98% | -97.22% | 430.62% | -16.29% | -23.55% |
| Foreign Exchange rate Adjustments | 150.68% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -92.85% | -165.89% | 85.76% | -3,001.50% | -290.83% |